Prevalence of Anemia in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis / 生物医学与环境科学（英文）

OBJECTIVE@#Anemia is a common public health concern in patients with type 2 diabetes worldwide. This study aimed to identify the prevalence of anemia among patients with diabetes.@*METHODS@#Electronic databases, including PubMed, Scopus, Web of Sciences, and Google Scholar, were searched systematically for studies published between 2010 and 2021. After removing duplicates and inappropriate reports, the remaining manuscripts were reviewed and appraised using theNewcastle-Ottawa Scale (NOS) tool. A random-effects model was used to calculate the pooled estimates of the extracted data using Stata version 17. Heterogeneity of the studies was assessed using the Q statistic.@*RESULTS@#A total of 51 articles containing information on 26,485 patients with diabetes were included in this study. The articles were mainly from Asia (58.82%) and Africa (35.29%). The overall prevalence of anemia was 35.45% (95% CI: 30.30-40.76), with no evidence of heterogeneity by sex. Among the two continents with the highest number of studies, the prevalence of anemia in patients with diabetes was significantly higher in Asia [40.02; 95% CI: 32.72-47.54] compared to Africa [28.46; 95% CI: 21.90-35.50] ( P for heterogeneity = 0.029). Moreover, there has been an increasing trend in the prevalence of anemia in patients with diabetes over time, from [15.28; 95% CI: 9.83-22.21] in 2012 to [40.70; 95% CI: 10.21-75.93] in 2022.@*CONCLUSION@#Globally, approximately 4 in 10 patients with diabetes suffer from anemia. Therefore, routine anemia screening and control programs every 3 months might be useful in improving the quality of life of these patients.

Analysis on the trends of incidence and age change for global female breast cancer / 中华肿瘤杂志

Objective: To analyze the trends of incidence and age change for global female breast cancer in different regions of the world according to the database from Cancer Incidence in Five Continents Time Trends (CI5plus) published by the International Association of Cancer Registries (IACR). Methods: The recorded annual female breast cancer (ICD-10: C50) incidence data and corresponding population at-risk data (1998-2012) were extracted from CI5plus published by IACR. The annual change percentage and average annual change percentage (AAPC) were calculated to examine the trends of incidence. The age-standardized mean age at diagnosis and proportion of incidence cases by age were calculated to analyze the relationship between incidence and age. Results: For crude incidence, except in Northern America, all other regions showed an upward trend, with Asia showing the most obvious upward trend (AAPC: 4.1%, 95% CI: 3.9%, 4.3%). For age-standardized incidence, in Asia, Latin America and Europe, the rising trends had slowed down, in Oceania and Africa, the trends began to be stable, and in Northern America, the trend showed a downward trend (APPC: -0.6%; 95% CI: -1.0%, -0.1%). The mean age at diagnosis were increased from 1998 to 2012 in Asia, Latin America, Oceania and Europe, with an annual increase of 0.12 years, 0.09 years, 0.04 years and 0.03 years, respectively. But after age-standardized, only Europe still kept increasing year by year, with an annual increase of 0.02 years, while Northern America showed a decreasing trend, with an annual decrease of about 0.03 years. Conclusions: From 1998 to 2012, the trends of incidence and age change for global female breast cancer vary in different regions of the world, and the global population aging is widespread, which affects the trend of the actual age change. Prevention and control strategies should be targeted at different age groups in different regions.

Prevalence of colorectal cancer in 2020: a comparative analysis between China and the world / 中华肿瘤杂志

Objective: To demonstrate the disease burden and epidemiological characteristics of colorectal cancer in different regions by analyzing the incidence and mortality data in China and worldwide in 2020. Methods: Estimation of the incidence and mortality data of colorectal cancer were obtained from the GLOBOCAN 2020 database. The incidence, death, age standardized incidence rate (ASIR) and age standardized mortality rate (ASMR) of colorectal cancer in China and 20 regions in the world were compared. The correlation between the Human Development Index (HDI) and ASIR/ASMR was analyzed. Results: In 2020, the number of new cases of colorectal cancer in the world reached 1 931 600, and the number of deaths reached 935 200. The incidence and mortality in all regions of the world continued to rise in the age group above 50 years old. The morbidity and mortality in male were higher than those in female. East Asia ranked the highest number of incidence cases and deaths in the world, which were 740 000 and 360 100 respectively. There were significant differences in incidence and mortality among regions in the world. The highest ASIR and ASMR were observed in Northern Europe (33.61/100 000) and Eastern Europe (14.53/100 000), whereas the lowest ASIR and ASMR were both observed in South-Central Asia (5.46/100 000 and 3.16/100 000). HDI had significant exponential relationship with ASIR (r(2)=0.59, P<0.001) and ASMR (r(2)=0.38, P<0.001). There were 555 500 new cases and 286 200 death cases of colorectal cancer in China, accounting for about 30% of the world and more than 75% of East Asia. The ASIR of China was 24.07/100 000, ranking at the medium level, while the ASMR was 12.07/100 000, ranking at the high level of world. Conclusion: The incidence and mortality of colorectal cancer are highly correlated with HDI. China is one of the countries with the heaviest disease burden of colorectal cancer in the world.

National policy actions on dementia in the Americas and Asia-Pacific: Consensus and challenges / Medidas políticas nacionales sobre la demencia en las regiones de las Américas y el Asia y el Pacífico: consenso y retos / Ações de políticas nacionais sobre demência nas regiões das Américas e Ásia-Pacífico: consenso e desafios

ABSTRACT Alzheimer's disease and related dementias (ADRD) affect over 50 million persons globally, and the number is expected to rise. In response, health ministries are developing and implementing policies and programs to systemically address the needs of individuals and families affected by ADRD. While national plans of action on ADRD are advancing among European Member States of World Health Organization (WHO), those in the Asia-Pacific and Americas are lagging behind. Since previous studies have largely ignored the Americas and Asia-Pacific—where approximately two-thirds of the global ADRD population resides—this study sought to identify (a) the socioeconomic factors associated with the likelihood of having a national dementia policy, and (b) to examine common and differing features among the national plans in these regions. Employing the dementia policy guidelines of WHO and the Pan American Health Organization as an extraction guide for data collection and analysis, the national dementia plans and available socioeconomic data of 10 Member States were analyzed with comparative and qualitative analyses. Findings suggested at least a 14-fold increase in the likelihood of having a national dementia plan if a Member State had one of the following: a universal health care system, more than 14% of the population 65 years of age or older, or high-income. All the Member States in the study identified dementia as a public health priority, but priorities differed. Inconsistencies included development of information systems, training for health care professionals, and long-term care systems.(AU)

RESUMEN La enfermedad de Alzheimer y otras demencias relacionadas afectan a más de 50 millones de personas a nivel mundial y se espera que esta cifra aumente. En respuesta, los ministerios de salud están elaborando y ejecutando políticas y programas para abordar de manera sistemática las necesidades de las personas y familias afectadas. Si bien los planes nacionales de acción sobre la enfermedad de Alzheimer y otras demencias progresan en los Estados Miembros europeos de la Organización Mundial de la Salud (OMS), los de las regiones de Asia y el Pacífico y las Américas están a la zaga. Puesto que en anteriores estudios se ha pasado por alto en gran parte a las regiones de las Américas y Asia y el Pacífico, donde residen aproximadamente dos terceras partes de la población mundial con estas enfermedades, en este estudio se ha tratado de: a) determinar los factores socioeconómicos relacionados con la probabilidad de contar con una política nacional en materia de demencia, y b) examinar las características comunes y distintas de los planes nacionales en esas regiones. Se examinaron los planes nacionales sobre demencia y los datos socioeconómicos disponibles de diez Estados Miembros mediante análisis comparativos y cualitativos en los que se emplearon las directrices para la formulación de políticas en materia de demencia de la OMS y la Organización Panamericana de la Salud a modo de guía de extracción para la recopilación y el análisis de datos. Los resultados indicaron que había un aumento de las probabilidades de al menos 14 veces de disponer de un plan nacional en materia de demencia siempre que el estado miembro contase con al menos uno de los siguientes elementos: un sistema de atención de salud universal, más de 14% de su población en la edad de 65 años o más, o ingresos elevados. Todos los Estados Miembros del estudio establecían la demencia como una cuestión prioritaria de salud pública, si bien las prioridades diferían. Entre las diferencias se encontraban el desarrollo de los sistemas de información, la capacitación de los profesionales de la salud y los sistemas de cuidados a largo plazo.(AU)

RESUMO A doença de Alzheimer e demências relacionadas (DADR) afetam mais de 50 milhões de pessoas em todo o mundo, e este número deverá aumentar no futuro. Em resposta, os ministérios da saúde estão desenvolvendo e implementando políticas e programas para atender sistematicamente às necessidades das pessoas e famílias afetadas pela DADR. Embora os planos de ação nacionais para a DADR estejam avançando entre os Estados Membros europeus da Organização Mundial da Saúde (OMS), os das regiões das Américas e Ásia-Pacífico estão ficando para trás. Estudos anteriores ignoraram amplamente as regiões das Américas e Ásia-Pacífico, onde encontram-se aproximadamente dois terços da população mundial com DADR; por isso, este estudo procurou (a) identificar os fatores socioeconômicos associados à probabilidade de que um país conte com uma política nacional para demência e (b) examinar as características comuns e diferentes dos planos nacionais existentes nessas regiões. Empregando as diretrizes para políticas sobre demência da OMS e da Organização Pan-Americana da Saúde como um guia para a coleta e análise de dados, examinamos os planos nacionais para demência e os dados socioeconômicos disponíveis em 10 Estados Membros, realizando análises comparativas e qualitativas. Os resultados sugeriram um aumento de pelo menos 14 vezes na probabilidade de que um Estado Membro conte com um plano nacional para demência quando esse Estado Membro apresenta um dos seguintes fatores: um sistema de atenção universal à saúde, mais de 14% da população com 65 anos de idade ou mais, ou alta renda. Todos os Estados Membros incluídos no estudo identificaram a demência como uma prioridade de saúde pública, mas com prioridades distintas. As diferenças incluíram o desenvolvimento de sistemas de informação, a formação oferecida aos profissionais da saúde e os sistemas de atenção à saúde de longa duração.(AU)

Expansão da circulação do vírus Zika da África à América, 1947-2018: revisão da literatura / Expansión de la circulación del virus Zika de África a América, 1947-2018: una revisión de literatura / Expansion of Zika virus circulation from Africa to the Americas, 1947-2018: a literature review

Objetivo: descrever as expansões temporal e geográfica da circulação do vírus Zika (ZIKV) em países e territórios, desde seu isolamento até 2018. Métodos: revisão não sistemática da literatura do período entre 1947 e 2018, utilizando a base MEDLINE e estimativas da Organização Mundial da Saúde. Resultados: desde seu isolamento em 1947, a circulação do ZIKV expandiu-se pela África, Ásia e Pacífico, até chegar à América em 2013, causando manifestações clínicas graves; as maiores soroprevalências foram registradas na ilha de Yap (74%) e no Brasil (63%); mutações genéticas, a ausência de imunidade e a alta susceptibilidade dos vetores podem ter influenciado sua transmissibilidade e ajudam a explicar a magnitude de sua expansão. Conclusão: a expansão da circulação do ZIKV nas Américas foi a mais ampla já registrada, possivelmente resultado de características populacionais e geográficas dos locais por onde o vírus circulou.

Objetivo: Describir las expansiones temporal y geográfica de la circulación del virus Zika en países y territorios, desde su aislamiento hasta 2018. Métodos: Revisión no sistemática de la literatura del período comprendido entre 1947 y 2018 utilizando la base MEDLINE y estimaciones de la Organización Mundial de la Salud. Resultados: Desde su aislamiento en 1947 la circulación del virus Zika se expandió por África, Asia y el Pacífico hasta llegar a América en 2013, causando manifestaciones clínicas graves. Las mayores seroprevalencias se registraron en la isla Yap (74%) y en Brasil (63%). Mutaciones genéticas, ausencia de inmunidad y alta susceptibilidad de los vectores pueden haber influenciado su transmisibilidad y ayudan a explicar la magnitud de su expansión. Conclusión: La expansión de la circulación del virus Zika en las Américas fue la más amplia ya registrada, posiblemente como resultado de características poblacionales y geográficas de los lugares por donde el virus circuló.

Objective: to describe the temporal and geographical expansion of Zika virus (ZIKV) circulation in countries and territories, from the time it was first isolated until 2018. Methods: This was a non-systematic literature review covering the period from 1947 to 2018 using the MEDLINE database and World Health Organization estimates. Results: Since its isolation in 1947, ZIKV circulation spread through Africa, Asia and the Pacific before reaching the Americas in 2013, causing serious clinical manifestations; the highest seroprevalence rates were recorded in Yap (74%) and in Brazil (63%); genetic mutations, absence of immunity and high vector susceptibility may have influenced ZIKV transmissibility and help to explain the magnitude of its expansion. Conclusion: The spread of ZIKV circulation in the Americas was the most extensive recorded thus far, possibly as a result of population and geographical characteristics of the sites where the virus circulated.

Alternative HPV vaccination schedules in Latin America / Los esquemas alternativos de vacunación contra VPH en América Latina

Abstract: In 2008, the first HPV vaccination program in Latin America started in Panama, targeting girls aged 10-11 years with a 3-dose vaccine schedule, an initiative that was to be followed by other Latin American countries after local feasibility and population acceptability evaluations were completed. A 3-dose vaccine regimen over six months was originally chosen for HPV vaccines, copying the Hepatitis B vaccine schedule (0, 1-2, 6 months). Alternative vaccine schedules have been proposed afterwards based on: i) noninferior immunogenicity or immune response levels compared to those at which clinical efficacy has been proven (i.e., those observed in a 3-dose HPV vaccine schedule in women aged 15-26), and, ii) proven efficacy in clinical trials and/or effectiveness among women who were provided less than three doses due to a lack of adherence to a 3-dose vaccine schedule. In 2014, based on the available evidence and the potential increase in coverage by expansion of vaccination target groups, particularly in low and middle income countries (LMIC), the World Health Organization recommended a 2-dose schedule with at least a 6-month interval between doses for females up to 15 years of age and a 3-dose schedule for older women. More recently, it has been suggested that 1-dose HPV vaccination schemes may provide enough protection against HPV infection and may speed up the introduction of HPV vaccination in LMIC, where most needed.

Resumen: En 2008, se inició en Panamá el primer programa de vacunación contra el virus del papiloma humano (VPH), dirigido a niñas de 10 a 11 años, utilizando un esquema de tres dosis en seis meses, iniciativa que fue adoptada por otros países de la región tras evaluar la aceptabilidad en la población y la viabilidad de llevar a cabo el programa. Inicialmente, el esquema de tres dosis para las vacunas contra el VPH se basó en el utilizado en la vacunación contra la hepatitis B (0, 1-2, 6 meses). Posteriormente, se han propuesto esquemas de vacunación alternativos, utilizando evidencia sobre: i) la inmunogenicidad o niveles de respuesta inmune no inferiores a aquéllos con los cuales la eficacia clínica de la vacuna fue probada (es decir, aquéllos observados con tres dosis en mujeres de 15 a 26 años); y ii) la eficacia demostrada en ensayos clínicos y efectividad demostrada en mujeres a quienes se vacunó con menos de tres dosis debido a falta de adherencia al esquema completo de tres dosis. En 2014, la Organización Mundial de la Salud recomendó un esquema de dos dosis con al menos seis meses de intervalo entre dosis para mujeres de hasta 15 años de edad y uno de tres dosis para mujeres mayores. La recomendación se basó en la evidencia disponible hasta entonces y a un posible aumento en cobertura mediante la ampliación de los grupos etarios a vacunarse, particularmente en países de ingresos bajos y medios (PIBMs). Más recientemente, se ha sugerido un esquema de vacunación contra el VPH de una sola dosis, el cual podría proporcionar suficiente protección contra la infección por VPH y así acelerar la introducción de la vacunación contra el VPH en PIBMs donde más se necesita.

Obesidade adulta nas nações: uma análise via modelos de regressão beta / Obesidad adulta en naciones: un análisis mediante modelos de regresión beta / Adult obesity in different countries: an analysis via beta regression models

Resumo: A obesidade é considerada um grave problema de saúde pública, por se tratar de uma doença epidêmica de grande repercussão no cenário mundial e que está relacionada ao desenvolvimento de outras doenças crônicas, como, por exemplo, hipertensão, diabetes e doenças cardiovasculares. Diante disso, o presente trabalho tem como objetivo estudar a distribuição da obesidade em adultos de diferentes nações, por meio do modelo de regressão beta. Trata-se de um estudo ecológico descritivo com abordagem quantitativa e inferencial com foco na análise de regressão beta. A aplicação desse método considerou um conjunto de dados reais, obtidos a partir de fontes de informação pública, referente à obesidade adulta nas nações no ano de 2014. Após a análise descritiva dos dados, verificou-se que 50% das nações apresentam uma prevalência de adultos obesos maiores que 0,20 (20%). Adicionalmente, ao analisar a distribuição de sua prevalência por nação, constatou-se que os menores valores de obesidade adulta estão concentrados nos países pertencentes aos continentes da Ásia e África. Por outro lado, os maiores valores encontram-se distribuídos entre os países nos continentes da América e Europa. Ainda, a partir da análise gráfica do boxplot, foram observadas evidências de uma possível diferença nas proporções de adultos obesos entre os continentes da América e Europa com os da África e Ásia. Após ajustar o modelo de regressão beta com dispersão variável, foi possível identificar, ao nível de 5% de significância, que as variáveis consumo médio de álcool em litros por pessoa, porcentagem de atividade física insuficiente, porcentagem da população que vive em áreas urbanas e expectativa de vida apresentam efeito.

Resumen: La obesidad está considerada un grave problema de salud pública, al tratarse de una enfermedad epidémica de gran repercusión en el escenario mundial, que está relacionada con el desarrollo de otras enfermedades crónicas, como, por ejemplo, hipertensión, diabetes y enfermedades cardiovasculares. Ante esto, el presente trabajo tiene como objetivo estudiar la distribución de la obesidad en adultos de diferentes naciones, mediante un modelo de regresión beta. Se trata de un estudio ecológico descriptivo con un abordaje cuantitativo e inferencial, centrándose en el análisis de regresión beta. La aplicación de este método consideró un conjunto de datos reales, obtenidos a partir de fuentes de información pública, referente a la obesidad adulta en las naciones durante el año 2014. Tras el análisis descriptivo de los datos, se verificó que el 50% de las naciones presentan una prevalencia de adultos obesos mayor de un 0,20 (20%). Asimismo, al analizar la distribución de su prevalencia por nación, se constató que los menores valores de obesidad adulta están concentrados en los países pertenecientes a los continentes de Asia y África. Por otro lado, los mayores valores se encuentran distribuidos entre los países en los continentes de América y Europa. Sin embargo, a partir del análisis gráfico del diagrama de caja, se observaron evidencias de una posible diferencia en las proporciones de adultos obesos entre los continentes de América y Europa, respecto a los de África y Asia. Tras ajustar el modelo de regresión beta con dispersión variable, fue posible identificar, con un nivel de un 5% de significancia, que variables como: el consumo medio de alcohol en litros por persona, el porcentaje de actividad física insuficiente, el porcentaje de la población que vive en áreas urbanas y su expectativa de vida presentan efectos en este sentido.

Abstract: Obesity is considered a serious public health problem, as an epidemic disease with major global repercussions that is associated with the development of other chronic conditions such as hypertension, diabetes, and cardiovascular diseases. The current study examines the distribution of adult obesity in different countries using a beta regression model. This is a descriptive ecological study with a quantitative and inferential approach and a focus on beta regression analysis. Application of this method used a set of real data from public sources on adult obesity in 78 countries in 2014. Descriptive data analysis showed that 50% of the countries showed adult obesity prevalence greater than 20%. In addition, analysis of the distribution of prevalence by country showed lower adult obesity levels in countries of Asia and Africa. Meanwhile, higher values were found in countries of the Americas and Europe. Boxplot analysis also evidenced a possible difference in the proportion of obese adults between the Americas and Europe on one side and Africa and Asia on the other. Adjustment of the beta regression model with varying dispersion and 5% significance identified mean annual per capita alcohol intake, percentage of insufficient physical activity, percentage of the population living in urban areas, and life expectancy as variables associated with adult obesity.

Yellow fever in Africa and the Americas: a historical and epidemiological perspective

Yellow fever was transported during the slave trade in the 15th and 16th centuries from Africa to the Americas where the virus encountered favorable ecological conditions that allowed creation of a sustainable sylvatic cycle. Despite effective vector control and immunization programs for nearly a century, yellow fever epidemics reemerged in many Latin American countries, particularly Brazil. The emergence or reemergence of vector-borne diseases encompasses many intricate factors. Yellow fever outbreaks occur if at least three conditions are fulfilled: the introduction of the virus into a non-immune human community, presence of competent and anthropophilic vectors and insufficiency of prevention and/or adequate management of the growing outbreak. On the other hand, two weapons are available to constrain yellow fever: vector control and immunization. In contrast, yellow fever is absent from Asia and the Pacific despite the presence of the vector and the susceptibility of human populations to the virus. Based on a review of the global history of yellow fever and its epidemiology, the authors deliver some recommendations for improving the prevention of epidemics.(AU)

Complications Requiring Hospital Admission and Causes of In-Hospital Death over Time in Alcoholic and Nonalcoholic Cirrhosis Patients

BACKGROUND/AIMS: Data on the epidemiology of alcoholic cirrhosis, especially in Asian countries, are limited. We compared the temporal evolution of patterns of alcoholic and nonalcoholic cirrhosis over the last decade. METHODS: We retrospectively examined the inpatient datasets of five referral centers during 2002 and 2011. The study included patients who were admitted due to specific complications of liver cirrhosis. We compared the causes of hospital admissions and in-hospital deaths between patients with alcoholic and nonalcoholic cirrhosis. RESULTS: Among the included 2,799 hospitalizations (2,165 patients), 1,496 (1,143 patients) were from 2002, and 1,303 (1,022 patients) were from 2011. Over time, there was a reduction in the rate of hepatic encephalopathy (HE) as a cause of hospitalization and an increase in the rate of hepatocellular carcinoma. Deaths that were attributable to HE or spontaneous bacterial peritonitis (SBP) significantly decreased, whereas those due to hepatorenal syndrome (HRS) significantly increased over time in patients with alcoholic cirrhosis. However, in patients with nonalcoholic cirrhosis, hepatic failure and HRS remained the principal causes of in-hospital death during both time periods. CONCLUSIONS: The major causes of in-hospital deaths have evolved from acute cirrhotic complications, including HE or SBP to HRS in alcoholic cirrhosis, whereas those have remained unchanged in nonalcoholic cirrhosis during the last decade.

Use of plasma triglyceride/high-density lipoprotein cholesterol ratio to identify increased cardio-metabolic risk in young, healthy South Asians.

Background & objectives: Prevalence of insulin resistance and associated dyslipidaemia [high triglyceride (TG) and low high-density lipoprotein cholesterol (HDL-C) concentrations] are increased in South Asian individuals; likely contributing to their increased risk of type-2 diabetes and cardiovascular disease. The plasma concentration ratio of TG/HDL-C has been proposed as a simple way to identify apparently healthy individuals at high cardio-metabolic risk. This study was carried out to compare the cardio-metabolic risk profiles of high-risk South Asian individuals identified by an elevated TG/HDL-C ratio versus those with a diagnosis of the metabolic syndrome. Methods: Body mass index, waist circumference, blood pressure, and fasting plasma glucose, insulin, TG, and HDL-C concentrations were determined in apparently healthy men (n=498) and women (n=526). The cardio-metabolic risk profile of “high risk” individuals identified by TG/HDL-C ratios in men (≥ 3.5) and women (≥2.5) was compared to those identified by a diagnosis of the metabolic syndrome. Results: More concentrations of all cardio-metabolic risk factors were significantly higher in “high risk” groups, identified by either the TG/HDL-C ratio or a diagnosis of the metabolic syndrome. TG, HDL-C, and insulin concentrations were not significantly different in “high risk” groups identified by either criterion, whereas plasma glucose and blood pressure were higher in those with the metabolic syndrome. Interpretation & conclusions: Apparently healthy South Asian individuals at high cardio-metabolic risk can be identified using either the TG/HDL-C ratio or the metabolic syndrome criteria. The TG/HDL-C ratio may be used as a simple marker to identify such individuals.

Prognostic value of hyponatremia in heart failure patients: an analysis of the Clinical Characteristics and Outcomes in the Relation with Serum Sodium Level in Asian Patients Hospitalized for Heart Failure (COAST) study

BACKGROUND/AIMS: Hyponatremia is a well-known risk factor for poor outcomes in Western studies of heart failure (HF) patients. We evaluated the predictive value of hyponatremia in hospitalized Asian HF patients. METHODS: The Clinical Characteristics and Outcomes in the Relation with Serum Sodium Level in Asian Patients Hospitalized for Heart Failure (the COAST) study enrolled hospitalized patients with systolic HF (ejection fraction < 45%) at eight centers in South Korea, Taiwan, and China. The relationship between admission sodium level and clinical outcomes was analyzed in 1,470 patients. RESULTS: The mean admission sodium level was 138 +/- 4.7 mmol/L, and 247 patients (16.8%) had hyponatremia defined as Na+ < 135 mmol/L. The 12-month mortality was higher in hyponatremic patients (27.9% vs. 14.6%, p < 0.001), and hyponatremia was an independent predictor of 12-month mortality (hazard ratio, 1.72; 95% confidence interval, 1.12 to 2.65). During hospital admission, 57% of hyponatremic patients showed improvement without improvement in their clinical outcomes (p = 0.620). The proportion of patients with optimal medical treatment was only 26.5% and 44.2% at admission and discharge, respectively, defined as the combined use of angiotensin-converting-enzyme inhibitor/angiotensin receptor blocker and beta-blocker. Underuse of optimal medical treatment was more pronounced in hyponatremic patients. CONCLUSIONS: In hospitalized Asian HF patients, hyponatremia at admission is common and is an independent predictor of poor clinical outcome. Furthermore, hyponatremic patients receive less optimal medical treatment than their counterparts.

A 2015 roadmap for the management of hepatitis C virus infections in Asia

The prevalence of hepatitis C virus (HCV) in Asia is 0.5% to 4.7%, with three different genotypes predominating, depending on the geographic region: genotype 1b in East Asia, genotype 3 in South and Southeast Asia, and genotype 6 in Indochina. Official approval for direct-acting antiviral agents (DAAs) in Asia lags significantly behind that in the West, such that in most countries the mainstay of therapy is still pegylated interferon and ribavirin (PR). Because the interleukin-28B genetic variant, associated with a high sustained virologic response (SVR), is common in Asians, this treatment is still acceptable in Asian patients with HCV infections. A roadmap for HCV therapy that starts with PR and takes into account those DAAs already approved in some Asian countries can provide guidance as to the best strategies for management, particularly of genotype 1 and 3 infections, based on SVR rates. Sofosbuvir and PR are likely to be the initial therapies for genotype 1 and 3 disease, although in the former these drugs may be suboptimal in patients with cirrhosis (62% SVR) and the extension of treatment to 24 weeks may be required. For difficult to treat genotype 3 infections in treatment-experienced patients with cirrhosis, a combination of sofosbuvir and PR result in an 83% SVR and is, therefore, currently the optimal treatment regimen. Treatment failure is best avoided since data on rescue therapies for DAA failure are still incomplete.

Clostridium difficile Infection: A Worldwide Disease

Clostridium difficile, an anaerobic toxigenic bacterium, causes a severe infectious colitis that leads to significant morbidity and mortality worldwide. Both enhanced bacterial toxins and diminished host immune response contribute to symptomatic disease. C. difficile has been a well-established pathogen in North America and Europe for decades, but is just emerging in Asia. This article reviews the epidemiology, microbiology, pathophysiology, and clinical management of C. difficile. Prompt recognition of C. difficile is necessary to implement appropriate infection control practices.

Genetic Diversity of Taenia asiatica from Thailand and Other Geographical Locations as Revealed by Cytochrome c Oxidase Subunit 1 Sequences

Twelve 924 bp cytochrome c oxidase subunit 1 (cox1) mitochondrial DNA sequences from Taenia asiatica isolates from Thailand were aligned and compared with multiple sequence isolates from Thailand and 6 other countries from the GenBank database. The genetic divergence of T. asiatica was also compared with Taenia saginata database sequences from 6 different countries in Asia, including Thailand, and 3 countries from other continents. The results showed that there were minor genetic variations within T. asiatica species, while high intraspecies variation was found in T. saginata. There were only 2 haplotypes and 1 polymorphic site found in T. asiatica, but 8 haplotypes and 9 polymorphic sites in T. saginata. Haplotype diversity was very low, 0.067, in T. asiatica and high, 0.700, in T. saginata. The very low genetic diversity suggested that T. asiatica may be at a risk due to the loss of potential adaptive alleles, resulting in reduced viability and decreased responses to environmental changes, which may endanger the species.

Comprehensive Review of Ocular Angiostrongyliasis with Special Reference to Optic Neuritis

Angiostrongyliasis, caused by Angiostrongylus cantonensis infection, is a food-borne parasitic disease. Its larvae evoke eosinophilic inflammation in the central nervous system, but can also cause pathological changes in the eyes. Among ocular angiostrongyliasis cases, the incidence of optic neuritis is low and only few sporadic reports exist. Some patients with optic neuritis developed obvious hypopsia or even vision loss, which would seriously influence the quality of life of patients. Prompt treatment of optic neuritis caused by A. cantonensis is the key factor for minimizing the incidence of serious complications of this disease. In this review, we first provide a comprehensive overview of ocular angiostrongyliasis, and then focus on the clinical features of optic neuritis caused by A. cantonensis.

Impact of dams and irrigation schemes in Anopheline (Diptera: Culicidae) bionomics and malaria epidemiology / Impacto de hidrelétricas e campos de irrigação na bionomia dos anofelinos (Diptera:Culicidae) e na epidemiologia da malária

Irrigation schemes and dams have posed a great concern on public health systems of several countries, mainly in the tropics. The focus of the present review is to elucidate the different ways how these human interventions may have an effect on population dynamics of anopheline mosquitoes and hence, how local malaria transmission patterns may be changed. We discuss different studies within the three main tropical and sub-tropical regions (namely Africa, Asia and the Pacific and the Americas). Factors such as pre-human impact malaria epidemiological patterns, control measures, demographic movements, human behaviour and local Anopheles bionomics would determine if the implementation of an irrigation scheme or a dam will have negative effects on human health. Some examples of successful implementation of control measures in such settings are presented. The use of Geographic Information System as a powerful tool to assist on the study and control of malaria in these scenarios is also highlighted.

Intervenções humanas como projetos de irrigação e usinas hidrelétricas, tem se transformado em graves problemas de saúde em muitos países, especialmente naqueles localizados nos trópicos. No presente artigo discutimos os efeitos que essas intervenções causam a dinâmica populacional dos anofelinos e nos padrões de transmissão de malaria. Foram revisados estudos feitos nas três principais regiões geográficas dos trópicos e sub-trópicos (África, Ásia e o Pacífico e Américas). Constatamos que os padrões da transmissão da malária antes da introdução dos empreendimentos, as medidas de controle, os movimentos demográficos, os padrões comportamentais das comunidades humanas e a bionomia dos anofelinos locais determinarão se o estabelecimento de campos de irrigação e/ou usinas hidrelétricas podem influenciar negativamente na saúde das pessoas. São apresentados exemplos de medidas de controle bem sucedidas nesses cenários. A utilização de Sistemas de Informação Geográfico tem sido destacada como uma importante ferramenta para subsidiar o estudo e controle da malária em áreas sob impacto ambiental.

Breast cancer in the world: Incidence and mortality

The aim of this paper is to describe the burden of breast cancer in the world, as the now most common cancer in women in the globe. Here a descriptive pattern based on information available in IARC and WHO databases describing estimated age-specific incidence is presented, both for incidence and mortality. The newer treatment modalities and screening programs have been developed to alleviate the burden of this disease, but much more needs to be done in the developing countries for the impact to reach outside of the developed nations.

El objetivo de este documento es describir la carga del cáncer de mama en el mundo, puesto que es el cáncer más común entre las mujeres del planeta. Aquí se presenta un patrón descriptivo basado en la información disponible en las bases de datos de la IARC y la OMS, describiendo estimaciones de la incidencia por grupos específicos de edad, tanto para incidencia como mortalidad. Las nuevas modalidades de tratamiento y programas de tamizaje se han desarrollado para aligerar la carga de esta enfermedad, pero necesita hacerse mucho más en los países en vías de desarrollo para que el impacto alcance más allá de las naciones desarrolladas.